Interesting how people interpret the same thing differently.
If (i) SOZO is truly the only device to capitalize on NCCN guidslines and (ii) the opportunity is as big as the CEO is presenting (he said this--single-company licence to captuere the market and surge in demand--has never/rarely happened in medical devices: it happens in drugs, but not medical devices; I listened the quarterly multiple times!): then the concern should be on take-overs given the tiny market cap compared to the (low-hanging fruit) opportunity.
IPD chart, page-633
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $89.01M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.3¢ | $257.5K | 5.914M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 101830 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 78860 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 101830 | 0.042 |
1 | 60000 | 0.041 |
5 | 457500 | 0.040 |
2 | 563845 | 0.039 |
1 | 50000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 78860 | 4 |
0.044 | 258923 | 1 |
0.045 | 770000 | 1 |
0.049 | 349500 | 2 |
0.050 | 28000 | 1 |
Last trade - 11.41am 11/09/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |